antibody-coupled T-cell therapy 2 (Unum Therapeutics)

N/A

Report date: 2025/01/26 16:19:59

Base Information

Drug Nameantibody-coupled T-cell therapy 2 (Unum Therapeutics)

Drug Alias Namemodified CD16 anti-Fc CAR T-cell therapy 2 (Unum Therapeutics)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionImmunostimulantsT lymphocytes stimulants

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCogent Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesCogent Biosciences Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A